Dermal Fillers 

RESTYLANE® is a gel containing hyaluronic acid and lidocaine, injected by a healthcare professional into or below the skin to smooth facial wrinkles and enhance lips by restoring volume and fullness. Restylane® is a Class III medical device with risks and benefits. It may cause redness, swelling, pain, tenderness, itching, or bruising, which may last a few days. Rarely, inflammatory reactions may occur up to 2–4 weeks post-treatment. Consult your healthcare professional if side effects concern you. Avoid excessive sunlight or extreme cold until redness or swelling subsides. Do not use Restylane® in areas with non-resorbable implants, irritated or infected skin, or in individuals taking blood-thinning medicines or with allergies to hyaluronic acid, lidocaine, or other local anaesthetics. Use with caution if taking medicines that prolong bleeding time. Treatment lasts 12–24 months. Restylane® has not been tested in pregnant or breastfeeding women. Always follow the instructions provided. Galderma, Auckland. Distributed by Healthcare Logistics, Auckland.

​

RESTYLANE® SKINBOOSTERS is a gel containing hyaluronic acid, injected into or below the skin to improve skin structure, hydration, and elasticity. Restylane® Skinboosters is a Class III medical device with risks and benefits. Do not use in patients with bleeding disorders or those taking blood-thinning medicines. Avoid injecting intravascularly or in areas with active disease, inflammation, infection, or tumours near the treatment site. Possible side effects include injection site reactions such as swelling, bruising, tenderness, and inflammation. Treatment typically lasts 6–12 months. Product and treatment costs apply. Consult your cosmetic practitioner for further details. Galderma, Auckland. Distributed by Healthcare Logistics, Auckland.

​

BELOTERO® is a Class III medical device used to smooth facial wrinkles and folds, correct facial atrophic scars, enhance lips, or restore facial volume. Belotero® has risks and benefits—ask your specialist if it’s suitable for you. It contains transparent cross-linked sodium hyaluronate gel of non-animal origin with 0.3% lidocaine to reduce local pain. Do not use if you have skin inflammation or infection until resolved. There is a risk of infection, and caution is advised if you’re on blood-thinning medicines, as bruising or bleeding at the injection site may increase. Possible side effects include swelling, bruising, redness, skin hardening, pain, altered colour, or itching. Treatment lasts 6–12 months. Product and doctor’s fees apply. Merz, Sydney. Distributed by Healthcare Logistics, Auckland.

​

TEOSYAL® PRODUCTS (including RHA® 1–4, Puresense Redensity 1–2, Puresense Kiss, Puresense Global Action, Puresense Deep Lines, Puresense Ultimate, Puresense Ultra Deep, Kiss, RHA® Kiss, Meso, Global Action, Deep Lines, Ultimate, and Ultra Deep) are Class III medical devices containing hyaluronic acid gel and 0.3% lidocaine hydrochloride. They smooth wrinkles, enhance lips, and restore volume. Teosyal® has risks and benefits. Use with caution in individuals on blood-thinning medicines. Possible side effects include inflammatory reactions (redness, swelling, pain at the injection site), bruising, itching, temporary loss of sensitivity, pigmentation changes, abscesses, nodules, or granulomas. Rare but serious risks from intravascular injection include temporary or permanent vision impairment, blindness, skin necrosis, or stroke. Treatment lasts 9–12 months. Consult your doctor for more information. Healthcare Logistics, Auckland.

​

SCULPTRA® is a Class III medical device used to restore facial volume by stimulating collagen production. Sculptra® has risks and benefits—ask your specialist if it’s suitable for you. It contains poly-L-lactic acid, which gradually improves volume in areas like cheeks and temples. Do not use in areas with active skin infections or inflammation, or in patients with a history of keloid scarring. Possible side effects include injection site reactions (redness, swelling, bruising, pain), nodules, or granulomas. Treatment effects develop over several months and may last up to 24 months. Product and doctor’s fees apply. Galderma, Auckland. Distributed by Healthcare Logistics, Auckland.